Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Largest Pharmacy Chains in the World

In this article, we will be analyzing the global pharmacy industry and its dominant players, while covering the 15 largest pharmacy chains in the world. If you wish to skip our detailed analysis, you can move directly to the 5 Largest Pharmacy Chains in the World.

The Global Pharmaceutical Industry to Reach $1.8 Trillion

According to a report by Research and Markets, the global pharmaceutical drugs industry was valued at $1.13 trillion in 2022. The industry is expected to grow from $1.19 trillion in 2023 to $1.84 trillion in 2027, at a compound annual growth rate of 11.4% over the forecast period. North America was the most dominant region in the pharmaceutical drugs market in 2022. However, the Middle East is expected to be the fastest growing market for pharmaceutical drugs.

Evolving Trends in the Industry

The pharmaceutical industry has been subject to external factors such as supply chain pressures in addition to rising inflation which has introduced additional costs of labor, raw materials, and transportation. Ever since the pandemic hit the industry, workers have been expecting more work flexibility which adds to the burden of already existing technical labor shortages for pharmaceutical companies. Hence, pharmaceutical companies are finding ways to leverage their positions by innovating, enhancing digitization, and collaborating with strategic partners across the industry. In October 2022, McKinsey reported that one way to leverage market position in the industry has been to enter joint ventures and partnerships. More than 50% of pharmaceutical companies expect to increase collaborations across the industry.

On January 6, PwC reported the emerging trends in the pharmaceutical industry for 2023. Pharmaceutical companies are trying to be cost-effective by achieving economies of scale through centralized operations. Outsourcing non-core processes to third parties has also been noticed since these third parties are capable of providing innovative solutions. A new era of treatment options is emerging as automation and artificial intelligence are being integrated into the drug development process, thereby saving time and costs.

Industry Rivalry

The global pharmaceutical industry is competitive since the market is saturated with many players. The most dominant players include CVS Health Corporation (NYSE:CVS), McKesson Corporation (NYSE:MCK), and Cardinal Health, Inc. (NYSE:CAH). Let’s take a look at some of the competitive moves by these players. You can also view the best healthcare stocks to buy now.

CVS Health Corporation (NYSE:CVS) is one of the world’s biggest healthcare companies. The company strives to improve healthcare access across the US. On October 1, CVS Health Corporation (NYSE:CVS) reported that its brand ‘Aetna’ will be launching the company’s largest Medicare offering, in 2024. The company will be increasing the access of 2.2 million more Medicare-eligible beneficiaries to an Aetna medicare advantage plan. Dental, vision, and hearing benefits have also been added to these plans. Furthermore, freshly prepared meals will also be delivered to patients after they get discharged from a hospital or a skilled nursing facility. The plans have been made affordable across the US.

McKesson Corporation (NYSE:MCK) is a leading distributor of pharmaceutical products and supplies. The company has constantly innovated to remain competitive in the market. Ontada is the company’s oncology technology business which aims to fight cancer in the country through its experience in real-world data research. On October 11, McKesson Corporation (NYSE:MCK) reported that Ontada has entered into a contract with the U.S. Food and Drug Administration (FDA) to research how rare cancers in patients are treated in the US community oncology setting. Ontada has secured this research since the company has access to almost 2.4 million patient records from a diverse patient group. This research will enable life science companies to improve drug development for better cancer care.

Cardinal Health, Inc. (NYSE:CAH) offers pharmaceutical products and provides personalized solutions to healthcare systems, pharmacies, and patients. The company has operations in more than 30 countries including the US and Canada. Considering supply chain volatility issues in the industry as mentioned above, the company has been investing in innovative technology to improve its value chain. On October 4, Cardinal Health, Inc. (NYSE:CAH) reported that it launched the InteLogix Platform at the beginning of 2023 as an efficient supply chain solution for hospitals. This platform uses AI and machine learning to balance demand and supply for health systems. InteLogix Contract Optimizer enables hospitals to make decisions regarding drug purchases through an analysis of purchase savings and alternative products. For hospitals that have employed this supply chain solution, savings of $8.25 million have been made.

You can also take a look at the highest paying countries for pharmacists. Now that we have taken a look at the industry, let’s move to the biggest pharmacy chains in the world.

15 Largest Pharmacy Chains in the World

Our Methodology

In order to compile a list of the largest pharmacy chains in the world, we consulted multiple industry analysis reports published by acclaimed market research agencies and we also tallied and sourced a list of global pharmacy retailers from stock screeners from Yahoo and Finviz. We sifted through our resources and compiled a list of the 30 biggest pharmacy companies by market cap. All market capitalizations have been mentioned in USD, as of October 12, 2023.

For companies that have a diversified business but a well-established pharmacy network, we cited the annual revenues from their pharmacy businesses, as of their latest fiscal year.

Finally, we ranked the top 15 largest pharmacy chains in the world in ascending order of their market capitalization, or revenue from their pharmacy business.

15 Largest Pharmacy Chains in the World:

15. Tsuruha Holdings Inc. (OTC:TSUSF)

Market Capitalization: $3.51 billion

Tsuruha Holdings Inc. (OTC:TSUSF) is a dominant pharmacy chain in the world. As a major drugstore network in Japan, the company is one of the leaders in regional medical care. Tsuruha Holdings Inc. (OTC:TSUSF) sells pharmaceuticals, food, cosmetics and miscellaneous products in the country. As of October 12, the company is worth $3.51 billion.

14. COSMOS Pharmaceutical Corporation (OTC:CSMYF)

Market Capitalization: $3.8 billion

COSMOS Pharmaceutical Corporation (OTC:CSMYF) is a pharmacy chain that operates drug stores in Japan and provides self-medication products, oral care products, diet supplements, and nursing care products. Other than healthcare products, COSMOS Pharmaceutical Corporation (OTC:CSMYF) also sells products related to hair care, cosmetics, and toiletries. The company has a market capitalization of $3.8 billion, as of October 12, and is one of the largest pharmacy networks in the world.

13. Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

Market Capitalization: $4.04 billion

Jointown Pharmaceutical Group Co., Ltd (SHA:600998) is a Chinese retailer of medical and pharmaceutical products. Apart from having one of the largest medical warehouse networks in China, the company serves worldwide. Jointown Pharmaceutical Group Co., Ltd (SHA:600998) also produces medical supplies such as gloves, medical equipment, and surgical masks.  As of October 12, the company is a major global pharmacy chain in the world and is worth $4.04 billion.

12. YSB Inc. (HKG:9885)

Market Capitalization: $4.3 billion

YSB Inc. (HKG:9885) is involved in the wholesale and retail of pharmaceutical and healthcare products. The company operates a digital platform for pharmaceutical retailers, vendors, and distributors to sell their products in China. YSB Inc. (HKG:9885) also offers a 24-hour service, wePharmacy, which helps connect consumers with pharmacist services. As of October 12, the company is valued at $4.3 billion and is one of the top pharmacy chains in the world.

11. Nahdi Medical Company (TADAWUL:4164) 

Market Capitalization: $4.73 billion

Nahdi Medical Company (TADAWUL:4164) is another large pharmacy chain in the world and has a market capitalization of $4.73 billion, as of October 12. The company is a dominant pharmaceutical retailer operating in the UAE and Saudi Arabia. Nahdi Medical Company’s (TADAWUL:4164) product portfolio includes wellness products, medicines, beauty products, and other FMCG products. E-Pharmacist is an online service by the company that enables access to the company’s pharmacists.

CVS Health Corporation (NYSE:CVS), McKesson Corporation (NYSE:MCK), and Cardinal Health, Inc. (NYSE:CAH) are global leaders in the pharmaceutical retail space which continue to fulfill medical requirements around the world.

10. Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)    

Market Capitalization: $4.81 billion

Yifeng Pharmacy Chain Co., Ltd. (SHA:603939) is a Chinese retailer of herbal medicines, western patent medicines, gynecological medicines, pediatric medicines,  medical equipment and health-related convenience products. The company operates a chain of pharmaceutical stores in Jiangsu, Shanghai, Zhejiang, Guangdong, and Beijing. As of October 12, Yifeng Pharmacy Chain Co., Ltd. (SHA:603939) is worth $4.81 billion on the open market and is one of the largest global pharmacy chains.

9. MatsukiyoCocokara & Co (TYO:3088) 

Market Capitalization: $7.64 billion

MatsukiyoCocokara & Co (TYO:3088) is another major player in the global pharmaceutical industry. The company operates a chain of drugstores and pharmacies. The product portfolio offered by the company is diversified and includes medical products, beauty products, cosmetics, and food products. The company’s stores operate across Japan, Thailand, Taiwan, Hong Kong, and Vietnam. As of October 12, MatsukiyoCocokara & Co (TYO:3088) is worth $7.64 billion on the open market.

8. Alibaba Health Information Technology Limited (OTC:ALBHF) 

Market Capitalization: $8.68 billion

Alibaba Health Information Technology Limited (OTC:ALBHF) is the digital health and pharmaceutical business of the Alibaba Group Holding Limited (NYSE:BABA). The company operates an e-commerce pharmaceutical and consumer healthcare services platform. Alibaba Health Information Technology Limited (OTC:ALBHF) is worth $8.68 billion as of October 12, 2023.

Companies dominating the global pharmaceutical industry include CVS Health Corporation (NYSE:CVS), McKesson Corporation (NYSE:MCK), and Cardinal Health, Inc. (NYSE:CAH).

7. Raia Drogasil S.A. (OTC:RADLY)

Market Capitalization: $9.53 billion

Raia Drogasil S.A. (OTC:RADLY) is one of the biggest drugstore companies in Latin America. The company operates Raia Drogasil as its pharmaceutical brand selling over-the-counter medications, infant milk, vitamins and food supplements. Other company brands offer hygiene, nutrition, and beauty products. As of October 12, Raia Drogasil S.A. (OTC:RADLY) is valued at $9.53 billion.

6. Welcia Holdings Co., Ltd. (TYO:3141)

Market Capitalization: $17.96 billion

Welcia Holdings Co., Ltd. (TYO:3141) is one of the world’s largest pharmacy chains, which operates a large drugstore network with dispensing pharmacies. It is a subsidiary of Aeon Co., Ltd. and is headquartered in Tokyo. Welcia Holdings Co., Ltd. (TYO:3141) retails daily household products, food, and cosmetics. Nursing care support services and housing services for the elderly are also offered by the company. As of October 12, the company is valued at $17.96 billion.

Click to continue reading and see 5 Largest Pharmacy Chains in the World.

Suggested articles:

Disclosure: None. 15 Largest Pharmacy Chains in the World is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…